Henry M. Sobell completed his studies at Brooklyn Technical High School (19481952), Columbia College (1952-1956), and the University of Virginia School of Medicine (1956-1960). Instead of practicing clinical medicine, he then went to the Massachusetts Institute of Technology (MIT) to join Professor Alexander Rich in the Department of Biology (1960-1965), where, as a Helen Hay Whitney Postdoctoral Fellow, he learned the technique of single crystal X-ray analysis. He then joined the Chemistry Department at the University of Rochester, having been subsequently jointly appointed to both the Chemistry and Molecular Biophysics departments (the latter at the University of Rochester School of Medicine and Dentistry), becoming a full tenured Professor in both departments (1965-1993). He is now retired and living in the Adirondacks in New York, USA.
Dr. Temple Smith graduated with a Ph.D. in Nuclear Physics from the University of Colorado in 1969. Then did a National Institutes of Health (USA) postdoctoral fellowship under the direction of the mathematician, Stanislaw Ulam, and the molecular biologist, John R. Sadler. There he carried out a detailed analysis of the E. coli Lac operator mutations. In 1979, Dr. Smith was one of the founders of GenBank, the US/NIH repository of Nucleic acid and protein sequences, initially at Los Alamos National Laboratory. There, he with Walter Goad developed a statistical mechanical model of the Lac operon system similar to those now being developed in systems biology. Dr. Smith is a co-developer with Michael Waterman of the Smith-Waterman sequence alignment algorithm, underlying most DNA and protein sequence comparison methods today. Dr. Smith spent a sabbatical year working with Harold Morowitz at Yale resulting in a seminal paper on the relationship between biology, physics and history. In 1988 he moved to the Harvard School of Public Health in Boston, there organizing a computational biology research center and initiating a series of international meetings, “Genes and Machines” on the application of computers in modern biology. In 1991 the center moved to Boston University, becoming the BioMolecular Engineering Research Center in the College of Engineering. Dr. Smith research has included, the evolution of protein structure;the modeling of the WD-repeat protein family with Dr. Eva Neer; the history of the Life Guard apoptotic regulatory protein family. Dr. Smith has served on a number of NIH and NSF review and advisory panels. As a member of Fly Base, he helped carry out a full-genome comparative evolutionary analysis of the Drosophila clade. More recently he has investigated the origin of the eukaryotic cell and the evolutionary of the cellular genetic translation system. In 2015 Dr. Smith was inducted as a follow of the American Association for the Advancement of Science (AAAS), as is also a fellow of the ISCB. He has over 200 reviewed publications. Dr. Smith was elected Emeritus Professor in BioMedical Engineering at Boston University, where he has continued his research and graduate student advising. Dr. Smith is an avid skier, ice climber, sailor, hockey coach and family man with four sons. He is also the co-founder of a small gene engineering company, Modular Genetics, Inc. in Woburn, MA.
Panagiotis Kollas is a new entrepreneur and a Scholar from the program SELECTUSA of the United States, through his participation to the Global Investment Summit of USA in 2015. Since then, he has founded the Global Corporation UNISCRAP PBC, a Public Benefit Corporation in the field of Environment. Panagiotis is an Impact Entrepreneur and Investor and Philosopher. He has passion to create benefits for young people related from different backgrounds, and Refugees as well. As a Young Entrepreneur has managed to create a Lean Business Model. His role is to create partnerships, design solutions and handle the Overall Strategy of the Organization
Nina is a CEO of Smart ECG Tech and a director of telemedicine at Magdalena Clinic for Cardiovascular Medicine, with more than 10 years experience in healthcare. She earned her Ph.D. in molecular biology at Pasteur Institute in Paris. Led multiple research project that were published among the highest ranking scientific publications, such as Nature and was awarded the Jacques Monod Prize for research in medicine granted by the French Foundation. Eager to accelerate translation of science to society, she earned an MBA from HEC and Wharton Business School and worked as a consultant for Dana Farber Cancer Institute on use of telemedicine for cancer diagnostics and therapy in Africa. In 2016, became alumni of Singularity University Exponential Medicine.
Eva K Lee is a professor in the H. Milton Stewart School of Industrial and Systems Engineering at Georgia Tech, and Director of the Center for Operations Research in Medicine and HealthCare. She is also a Senior Research Professor at the Atlanta VA Medical Center. Dr. Lee was awarded a NSF/NATO postdoctoral fellowship on Scientific Computing, and a postdoctoral fellowship from Konrad-Zuse-Zentrum Informationstechnik Berlin in 1995 for Parallel Computation. In 1996, she received the NSF Presidential Young Investigator Award for research on integer programming and parallel algorithms and their applications to medical diagnosis and cancer treatment. She was the first OR/IE recipient for the prestigious Whitaker Foundation Biomedical Grant for Young Investigators, awarded for her work on a novel approach for combining biological imaging and optimal treatment design for prostate cancer. In 2004, she was selected as one of the Extraordinary Women Engineers. In 2005, she received the INFORMS Pierskalla award for research excellence in HealthCare and Management Science for her work on emergency response and planning, large-scale prophylaxis dispensing, and resource allocation for bioterrorism and infectious disease outbreaks. In 2006, she was chosen by the American Mathematical Society as the representative mathematician to speak and discuss individually with congressional leaders about her research advances in the medical and healthcare domain, and about the importance of mathematics in scientific advances. Together, Lee and Dr. Marco Zaider from Memorial Sloan-Kettering Cancer Center were named winners of the 2007 Franz Edelman award for their work on using operations research to advance cancer therapeutics. Lee has received seven patents for innovative medical systems and devices. Her research has been featured and discussed in numerous news media articles, including articles in the New York Times, London Times, Urology Times, Atlanta Business Chronicle, and Homeland Security IAIP Directorate Daily Report. Her cancer research was featured in a TV science news segment for Discoveries and Breakthroughs, Inside Science, Curing Prostate Cancer, broadcast by television stations nationwide. Lee's teaching includes Engineering Optimization, Operations Research in Medicine and HealthCare, Cancer Biology and Biotechnology, and Biomedical Informatics and Predictive Models. Besides the graduate program in Industrial and Systems Engineering, she is also a program faculty of several interdisciplinary graduate programs, including Algorithms, Combinatorics, and Optimization (ACO); Bioinformatics; Bioengineering; and Health Systems.
Dr. Brij. M. Gandhi, M.Sc.(Biochemistry) and Ph.D.(Experimental Medicine, Norway) is presently CEO and founder of Neo BioMed Services (www.neobiomed.com), providing services and consultancy in health areas and regulatory issues related to biopharmaceuticals, pharmaceuticals, including stem cell and regenerative medicine. As Adviser to the Government of India, Dr. Gandhi was involved in management, promotion and policy issues in biotechnology related to international collaborations, medical biotechnology including stem cells and regenerative medicine, infrastructure development, animals and aquaculture biotechnology, biosafety and biosecurity. Prior to that he was Research Scientist at AIIMS, New Delhi working on immunology of parasitic, bacterial and viral infections including amoebic diseases; hepatitis; liver diseases; IVD; food and nutritional health issues. Dr. Gandhi was trained at MIT, USA; LSHTM, London, NIH, USA, Hvidovre Hospital, Copenhagen and University of Bergan, Norway. Dr. Gandhi continues to serve as Advisor / Director to a number of institutions/pharma and biopharma industries with an experience of about 50 years as research scientist, science manager, adviser/consultant and having over 155 publications
Zeliha Selamoglu is a Professor in Medical Biology department of Nigde Ömer Halisdemir University, Turkey. She earned her PhD in Biology from Inonu University, She has published over 120 peerreviewed journal articles with over 1100 citations and many technical reports. She is a member of Society for Experimental Biology and Medicine: Associate Membership and European association for cancer research. She has served as Editorial Board member for many Journals. h-index: 15 citations: 1100
ILKNUR BABAHAN, PhD She received Ph.D. degree in Organic Chemistry from Ege University, Izmir, Turkey in 2005. Since 2005, She has been with the Faculty of Arts and Sciences, Adnan Menderes University (Aydin, Turkey), where she is currently an Associate Professor. She went on to do postdoctoral work at The University of Akron (Akron, OH, USA) in 2012 and at Morgan State University (Baltimore, MD, USA) in 2015. She is currently working on organic coatings, synthesis of polymeric resins and their formulations, at the department of Polymer Engineering in University of Akron (Akron, OH), as a Visiting Scientist. Her main areas of research interest are Organic Synthesis, Organometallic Chemistry and Medicinal Chemistry. Her current research interests include ❖ Synthetic Organic Chemistry (new methodology; small molecule synthesis; heterocyclic chemistry); design and synthesis of novel ligands and their metal complexes which may be used as “smart medicine” in cancer therapy. ❖ Organometallic Chemistry/Homogeneous and Heterogeneous Catalysis (ligand design and synthesis; design and synthesis transition metal complexes; transition metal catalysis). ❖ Synthesis of polymeric resins (Alkyd/Epoxies/Acylates/Urethanes) and development of new UV curable materials.
Ali Fouladkar, 28 years old, a researcher in Big Data field, deals with the concept of Big Data, Weak Signal and Strategic Decision. Information System lecturer at Grenoble Graduate Business School (IAE Grenoble), and Editorial Board Member of “Advances in Bioengineering and Biomedical Science Research”. The purpose of his thesis “Detection and Interpretation of weak signals from big data for a strategic decision : pre-adoption of new technology” is to identify which Communities of the Organizing Vision influence the decision of adoption of Big Data technologies to detect weak signals and support strategic decision. In the Bachelor and Master Degree level, he achieved the first rank in his universityin the field of Business Management. Ali participated in many Research Days and Round Table related to Big Data issues in USA and France. His researchers presented and cited at high-level international conferences (World Summit on Big Data and Organization Design, EdCon 2013 'IBM annual largest conference', MIT Sloan Management Review).
Viktor I. Sevastianov graduated Medical Institute, Moscow in 1969 (biophysics). He defended his Ph.D. (Candidate of Sciences, Physical Chemistry) at Institute of Chemical Physics, U.S.S.R Academy of Sciences, Moscow in 1973 and Doctor of Sciences Degree (Biophysics) at Research Institute of Transplantology an Artificial Organs in 1985, Professor (Biophysics) since 1992. At present time Prof. V.I. Sevastianov is Head of Department for Biomedical Technology and Tissue Engineering at Shumakov National Medical Research Center of Transplantology and Artificial Organs and Head of Autonomous Non-Commercial Organization “Institute of Biomedical Research and Technology”, Moscow, Russia. He is Head of Russian Committee TK 422 for Standardization “Biological Safety of Medical Devices” (2009 to present), Editorial Board of J. of Biomedical Materials Research, Russian J. of Transplantology and Artificial Organs, Advanced Biomaterials and Devices in Medicine, Progress in Biomaterials , Trends in Biomaterials & Artificial Organs International Journal, J. Advanced of Materials (Russ), Bio-Inspired Nanotechnology. The areas of his research is Blood Compatible Biomaterials, Coatings and Medical Devices (Total Artificial Heart, Assist Devices, Vascular Grafts, Artificial Kidney, Hemosorbents, Artificial Valves), Blood, Tissue/Material Interactions (Protein Adsorption, Blood Cells Reaction, Complement Activation, Calcification), Drug Delivery Systems, Tissue Engineering and Regenerative Medicine. Supervised the defense of 14 B.S., 27 M.S., 33 Ph.D. and 6 Dr. Sci. Main scientific results are presented in 283 publications, 53 Russian Patents and 4 EC Patents.
Zhangisina Gulnur Davletzhanovna is Vice-¬President of the International Academy of¬ Informatization from 24 November 2016 ye¬ar. She is candidate of engineering scien¬ces, doctor of pedagogic sciences, profes¬sor, honorary educationalist of the Repub¬lic of Kazakhstan, academician of the Int¬ernational Academy of Informatization, wi¬nner of the State grant «The best univers¬ity teacher» (2005) and State scientific ¬scholarship for scientist and specialists¬, who made a major contribution to the de¬velopment of science and engineering (200¬6-2008), the holder of Gold Medal «Europe¬an Quality(2014 y.)», Honored Worker of S¬cience and Education of Russia, Correspon¬ding Member of the Russian Academy of Nat¬ural Sciences, Academician of the Interna¬tional Academy of Informatization. Zhangi¬ssina G.D. -author of 5 monographs, over -20 learning aids and more than 400 scient¬ific publications. She is listed in data ¬base of leading scientists and teachers o¬f the Ministry of Education and Science o¬f the Republic of Kazakhstan (July, 2005 ¬y.). Zhangisina G.D. has over 100 publica¬tions in Europe (Germany, Bulgaria, Polan-d, CzechRepublic, Spane), in Turkey, USA,¬ India, Canada and CIS countries (Russia,¬ Ukraine, Byelorussia, Kyrgyzstan, Uzbeki¬stan). Under the guidance of Zhangisina G¬.D. three postgraduate students has succe¬ssfully defended their theses, one of the¬m took degree of doctor of engineering sc¬iences and two of them took the degree of¬ candidate of engineering sciences (speci¬alty 05.13.15 – Computing machines and sy¬stems). She was also a scientific adviser¬ of 5 magistracy students, who have succe¬ssfully defended their theses and took th¬eir master’s degrees on specialty 6М07040¬0 – Computer science and software enginee¬ring and 1 Magister get 2- nd degree in i¬nformation security in St. Petersburg, In¬stitute of mechanics, optics and informat¬ion technology(2014 y.). In 1992 Zhangisi¬na G.D. she graduated from postgraduate c¬ourse of Moscow energy university on spec¬ialty 05.13.13 – Computing machines, comp¬lexes, systems and networks. She is a spe¬cialist in the field of parallel computin¬g and informatization of education. Resul¬ts of her research work were implemented ¬in the leading universities of the Republ¬ic of Kazakhstan, Russia, Uzbekistan and ¬Germany. She has 2 Patents (2016&2017 yea¬rs); Author Certificates; she was the Mem¬ber of Organization Committee in the Worl¬d Congress "Petrochemistry 2017"; Interna¬tional Conference in Russia(Miscow, Simfe¬ropol,Sanct-Piterburg) in 2015-2017 years¬; in Ukraine-Kiev(2013).In 2018 year she ¬was the Member of Organization Committe¬te of 9-th International Conference an¬d Expo on Separation Techniques in Zurich¬, Switzerland(13-14 September 2018 year),¬ 3-rd International Conference and Expo ¬on Petrochemistry&Natural Resources in ¬Prague, Czech Republic(22-23 October 201¬8).
Sergey Suchkov was born in the City of Astrakhan, Russia, in a family of dynasty medical doctors. In 1980, graduated from Astrakhan State Medical University and was awarded with MD. In 1985, maintained his PhD as a PhD student of the I.M. Sechenov Moscow Medical Academy and Institute of Medical Enzymology, USSR Academy of Medical Sciences, Moscow, Russia. In 2001, finished the PostDoc Research Fellowship Program and maintained his Doctor Degree at the National Institute of Immunology, Russia. From 1985 through 1987, worked at Inst of Med Enzymology, USSR Academy of Medical Sciences. From 1987 through 1989, was a senior Researcher, Koltzov Inst of Developmental Biology, USSR Academy of Sciences. From 1989 through 1995, was being a Head of the Lab of Clinical Immunology and Immunobiotechnology, Helmholtz Eye Research Inst in Moscow. From 1995 through 2004, was being a Chairman of the Dept for Clinical Immunology, Moscow Clinical Research Institute (MONIKI) and the Immunologist-in-Chief of the Moscow Regional Ministry of Health. In 1993-1996, was an Executice Secretary-in-Chief of the Editorial Board, Biomedical Science, an international journal published jointly by the USSR Academy of Sciences and the Royal Society of Chemistry, UK. Dr Suchkov is a Co-Supervisor over the Russian-American Agreement on scientific and clinical collaboration in the field of ocular immunology between Russian Academy of Sciences and National Institutes of Health (NIH); in 1991-1995 – a member of The Reciprocal Exchange Fellowship Program between Russian Immunological Society and British Society for Immunology. Dr Suchkov is a member of the Editorial Boards of many international journals including EPMA Journal (Springer, Brussels) and “Personalized Medicine Universe” (Elsevier, Japan).
He is Completed Bachelor of Science (honorary), Hebrew University Jerusalem, Israel, 1994. Master of Science (honorary), Hebrew University Jerusalem, Israel, 1996. Doctor of Philosophy (honorary), Hebrew University Jerusalem, Israel, 1999. Teaching assistant Hebrew University Jerusalem, 1995—1999. Director r&d & business development Epigenesis Ltd., 1999—2001. Project manager gpcr Compugen Ltd., Tel Aviv, since 2001.Associate director genetics IDGene Ltd., Jeruslaem, 2001. First sergeant Medic-Infentry, Israel Defense Forces, Israel, 1986—1995. Achievements include patents for bio-therapeutics & discovery of novel proteins, variants & drug candidates.
Hedayat Omidvar Graduated in Industrial Engineering (MSc) in 2002. He has been working since 1992 as Natural Gas consumption expert in Corporate Planning Dept., National Iranian Gas Company (NIGC), responsible for treatment, transmission, storage and distribution of natural gas. At present, he is Head of Communication Affairs with Science & Research Centers, Research & Technology Dept. Member of Institute of Industrial Engineers (IIE) since 1992 Member of American Industrial Hygiene Association (AIHA) since 1994 Member of Iran Institute of Industrial Engineering (IIIE) since 2001 Member of Program Committee A (PGC A) “Sustainable Development” of the International Gas Union (IGU) 2003-2006 Member of Marketing and Communication Committee (PGC E) of the International Gas Union (IGU) 2006-2012 Member of Gas Advocacy Task Force (TF2) of the International Gas Union (IGU) 2012-2015 Secretary of Utilization Committee of the International Gas Union (IGU) 2015-2018 Member of Marketing and Communication committee of the International Gas Union (IGU) 2015-2018 Member of Executive Committee of the International Gas Union (IGU) 2015-2018 Chair of Energy Policy Task Force (TF3) of the International Gas Union (IGU) 2018-2021 Member of Group of Experts on Gas of United Nations Economic Commission for Europe (UNECE) from 2016 Letter of Commendation As the Exemplary Research Expert Received From the Deputy Petroleum Minister & Managing Director of NIGC 2008 Letter of Commendation Received From the Deputy Petroleum Minister & Managing Director of NIGC 2011 Letter of Commendation Received From the Deputy Petroleum Minister & Managing Director of NIGC 2013
Majid Ghassemi is a Professor of Mechanical Engineering Department at the K. N. Toosi University of Technology in Tehran, Iran. He has over 20 years of academic and industrial experience and served as the President of the K. N. Toosi University of Technology from 2010 through 2013. Professor Ghassemi has also served in several public and private boards and panels and supervised several undergraduate, masters and PhD students, published several books and many journal and conference papers. He is currently an Editor-in-Chief of the International Journal of Prevention and Treatment and Managing Editor of the American Journal of Mechanical Engineering (AJME) as well as Editorial Board member for many international journals. He also serves as member in several international conferences. Professor Ghassemi received his Ph.D. in Mechanical Engineering from Iowa State University in 1993.
Loai Aljerf is a Prof in the Department of Basic Sciences, Faculty of Dental Medicine/Damascus University. He is a specialist in analytical and industrial chemistry. He obtained many awards and published more than 30 peer-reviewed papers (two of them in French) in Environmental Sciences, Green Chemistry, Analytical Chemistry, Synthesis Chemistry, Concrete, Ceramics, Paper Industry, Petrochemical, Extraction, Separation, Lithium-Ion-Batteries, and Oral Chemistry. He is a partner in Advances in Cleaner Production Network, and a member of the German Chemical Society e.V. (GDCh) and the American University of Beirut. He is a member of the higher committee of the 6th International Workshop-Advance in Cleaner Production (São Paulo, Brazil (May 24th to 26th - 2017)). Loai Aljerf is in the Cambridge Scholars Publishing-Life Science Advisory Board and an editor of more than 50 journals and a reviewer for Top journals in Industry, Chemical Engineering, and Environmental Chemistry.